Clinical Trials Browser

Terminated × Neoplasms × Sorafenib × Clear all

NCT03582618 2023-01-10

CVM-1118 and Sorafenib Combination in Subjects With Advanced Hepatocellular Carcinoma

Phase 2 Terminated

Gastrointestinal

Carcinoma, Hepatocellular, Neoplasms

NCT00352859 2014-12-30

Phase IV Randomization to On-Going Treatment to Evaluate Sustained Sorafenib

Phase 4 Terminated

Carcinoma, Renal Cell, Neoplasms

NCT00110344 2013-10-11

Research Study for Patients With Metastatic Renal Cell Carcinoma

Phase 2 Terminated

Carcinoma, Renal Cell, Neoplasms

NCT01009593 2012-09-10

Efficacy and Tolerability of ABT-869 Versus Sorafenib in Advanced Hepatocellular Carcinoma (HCC)

Phase 3 Terminated

Gastrointestinal

Adenocarcinoma, Carcinoma, Digestive System Diseases, Digestive System Neoplasms, Carcinoma, Hepatocellular, Liver Diseases, Liver Neoplasms, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Glandular and Epithelial